E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/23/2006 in the Prospect News Bank Loan Daily and Prospect News Biotech Daily.

S&P gives Kendle International, loan B+

Standard & Poor's said it assigned its B+ corporate credit rating and stable outlook to Kendle International Inc.

At the same time, S&P said it assigned its B+ bank loan rating to the company's proposed $25 million senior secured revolving credit facility due in 2011 and $200 million senior secured term loan due in 2012, with a recovery rating of 3.

S&P added that the ratings on Kendle reflect the company's high leverage and integration risk related to the acquisition of CRL Clinical Services, which provides services from phase 2 trials through postmarketing studies.

These risks are partially offset by the company's growing position in a fairly fragmented market, its global presence and the diverse therapeutic areas served, the agency noted.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.